Integra LifeSciences Unveils New Change-in-Control Severance Program for Executives
Integra LifeSciences Holdings Corporation has adopted a new change in control severance program effective January 1, 2026, covering select executives including Executive Vice President and CFO Lea Knight, among others. Under the program, participants are eligible for severance benefits if their employment is terminated without cause or for good reason within two years following a change in control, provided such an event occurs by December 31, 2026. Benefits include a lump sum payment equal to 1.5 times the sum of annual base salary and target cash bonus (2 times for Ms. Knight), a pro rata lump sum of the target bonus for the year of termination, up to 18 months of company-subsidized COBRA premium payments, and up to 12 months of company-paid outplacement services. The program also ensures payment of any outstanding short-term annual cash bonus for prior-year performance. The term of the program expires at the end of 2026 unless extended by the board, and will automatically extend for two years if a change in control occurs.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Integra LifeSciences Holdings Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000917520-25-000100), on December 12, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.